HbA1c below 7% as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
about
Continued efforts to translate diabetes cardiovascular outcome trials into clinical practiceCurrent perspectives on cardiovascular outcome trials in diabetesDose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure.Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention.Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.Cardiovascular disease prevention strategies for type 2 diabetes mellitus.Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002-2014).Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG).Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data.Impaired Left Atrial Conduit Function in Coronary Artery Disease Patients With Poorly Controlled Diabetes: Two-Dimensional Speckle-Tracking Echocardiographic Study.
P2860
Q26741860-5A378052-15AD-4E11-804D-B181A4BC7DD2Q28066006-0BCC8260-648C-4FFD-A975-82383DCEDD86Q33815573-82983BAD-75B7-49CB-B19D-86C56ED7E6EEQ36016740-0A2DBE17-61BB-42CF-936E-180037CED86FQ36715249-DA0EE89A-6F6F-415F-9DC3-247B263C662AQ37107872-F01D954D-04AF-4A64-85F5-9C23A6F83248Q39420208-62C5076E-A463-4CFF-9A96-D8F58375DA3AQ42374460-807DA6D2-BB24-412C-BE07-1A206632D6B5Q42643753-EACB89B3-690D-45BB-A33C-CD17D3A7F3E2Q47144821-2BD1C00B-8282-45EB-A4FE-ADB44589E97EQ48585297-E9320B88-0983-4B17-A239-73D8D5D2E438
P2860
HbA1c below 7% as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HbA1c below 7% as the goal of ...... ular benefits: a meta-analysis
@ast
HbA1c below 7% as the goal of ...... ular benefits: a meta-analysis
@en
type
label
HbA1c below 7% as the goal of ...... ular benefits: a meta-analysis
@ast
HbA1c below 7% as the goal of ...... ular benefits: a meta-analysis
@en
prefLabel
HbA1c below 7% as the goal of ...... ular benefits: a meta-analysis
@ast
HbA1c below 7% as the goal of ...... ular benefits: a meta-analysis
@en
P2093
P2860
P1476
HbA1c below 7% as the goal of ...... ular benefits: a meta-analysis
@en
P2093
Haixia Sun
Rong Huang
Rongrong Cai
Shaohua Wang
Wenqing Xia
P2860
P2888
P356
10.1186/S12933-015-0285-1
P407
P577
2015-09-22T00:00:00Z
P5875
P6179
1049898187